Last reviewed · How we verify
Docetaxel, trastuzumab
At a glance
| Generic name | Docetaxel, trastuzumab |
|---|---|
| Sponsor | Jiangsu HengRui Medicine Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Docetaxel, trastuzumab CI brief — competitive landscape report
- Docetaxel, trastuzumab updates RSS · CI watch RSS
- Jiangsu HengRui Medicine Co., Ltd. portfolio CI